Baver, S
Im a hair restoration surgeon for patients who have already seen dermatologists and have already done the preemptive work, says Dr
Cardiovascular Outcomes Data The SELECT trial (N=17,604) published in the New England Journal of Medicine in 2023 showed that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% versus placebo in adults with overweight or obesity and established cardiovascular disease, over a mean follow-up of 34 months [11]
Risk 1: It is not an approved cosmetic tanning drug Melanotan II is not an FDA-approved cosmetic tanning drug in the United States
Sources: Mayo Clinic: Semaglutide (Subcutaneous Route) Wegovy: Starting Wegovy Pill Diabetes Care: Gradual Titration of Semaglutide Results in Better Tolerability Ozempic: Dosing Information Wharton S, Freitas P, Hjelmesaeth J, et al
There is growing evidence that GLP 1 receptors are commonly expressed in the pancreas (, and cells), lung, heart, kidney, stomach, intestine, pituitary gland, skin, vagal ganglia, and multiple regions of the central nervous system (including brainstem, hypothalamus, hippocampus and cortex), determining the diversity of GLP 1 physiological actions
